Laureen DeBuono - 04 Oct 2021 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)

Role
Director
Signature
/s/ Sandra Gardiner, as Attorney-in-Fact
Issuer symbol
PLSE
Transactions as of
04 Oct 2021
Net transactions value
$0
Form type
4
Filing time
06 Oct 2021, 16:11:13 UTC
Previous filing
02 Aug 2021
Next filing
27 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLSE Stock Option (right to buy) Award $0 +32,500 $0.000000 32,500 04 Oct 2021 Common Stock 32,500 $20.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third (1/3) of the shares subject to the option will vest on October 4, 2022, and the remaining shares will vest in equal monthly installments thereafter over the following two year period, subject to the Reporting Person's continued service through each vesting date.